These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 25885028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
    Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.
    BMC Cancer; 2008 Jun 09; 8():165. PubMed ID: 18541009
    [Abstract] [Full Text] [Related]

  • 3. Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.
    Park J, Byun BH, Noh WC, Lee SS, Kim HA, Kim EK, Choi CW, Lim SM.
    Clin Nucl Med; 2014 Apr 09; 39(4):e249-53. PubMed ID: 24152622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.
    Eur J Nucl Med Mol Imaging; 2004 Jun 09; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [Abstract] [Full Text] [Related]

  • 6. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
    Ahn JH, Son EJ, Kim JA, Youk JH, Kim EK, Kwak JY, Ryu YH, Jeong J.
    Acta Radiol; 2010 Oct 09; 51(8):859-65. PubMed ID: 20670083
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T, Yajima R, Tatsuki H, Kuwano H.
    Anticancer Res; 2016 Apr 09; 36(4):1785-9. PubMed ID: 27069160
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
    Kitajima K, Fukushima K, Miyoshi Y, Katsuura T, Igarashi Y, Kawanaka Y, Mouri M, Maruyama K, Yamano T, Doi H, Yamakado K, Hirota S, Hirota S.
    Jpn J Radiol; 2016 Mar 09; 34(3):220-8. PubMed ID: 26715510
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug 09; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 14. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
    Jung NY, Kim SH, Kang BJ, Park SY, Chung MH.
    Breast Cancer; 2016 Sep 09; 23(5):712-7. PubMed ID: 26219608
    [Abstract] [Full Text] [Related]

  • 15. Preoperative FDG-PET for axillary metastases in patients with breast cancer.
    Chung A, Liou D, Karlan S, Waxman A, Fujimoto K, Hagiike M, Phillips EH.
    Arch Surg; 2006 Aug 09; 141(8):783-8; discussion 788-9. PubMed ID: 16924086
    [Abstract] [Full Text] [Related]

  • 16. FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer.
    Kumar R, Zhuang H, Schnall M, Conant E, Damia S, Weinstein S, Chandra P, Czerniecki B, Alavi A.
    Nucl Med Commun; 2006 Mar 09; 27(3):231-6. PubMed ID: 16479242
    [Abstract] [Full Text] [Related]

  • 17. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
    Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, Spano G, Luini A, Intra M, Veronesi P, Berrettini A, Paganelli G.
    Ann Oncol; 2007 Mar 09; 18(3):473-8. PubMed ID: 17164229
    [Abstract] [Full Text] [Related]

  • 18. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.
    Breast J; 2004 Mar 09; 10(2):101-5. PubMed ID: 15009035
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
    Orsaria P, Chiaravalloti A, Caredda E, Marchese PV, Titka B, Anemona L, Portarena I, Schillaci O, Petrella G, Palombi L, Buonomo OC.
    Anticancer Res; 2018 Dec 09; 38(12):6639-6652. PubMed ID: 30504372
    [Abstract] [Full Text] [Related]

  • 20. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
    Fujii T, Yajima R, Tatsuki H, Oosone K, Kuwano H.
    Anticancer Res; 2016 Jan 09; 36(1):393-7. PubMed ID: 26722071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.